Physician profile
Asish Mukherjee
NPI 1386607513
$1,325.74
in general payments reported to CMS, 2019-2025
18 companies · $17.07 in 2025
The $17.07 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $123 · 2021: $186 · 2022: $493 · 2023: $67.20 · 2024: $112 · 2025: $17.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $295.94 | 2019-2023 | Trulance, Xifaxan |
| Medtronic, INC. | $151.11 | 2022 | |
| Mallinckrodt Enterprises LLC | $140.11 | 2019 | |
| Smith+Nephew, INC. | $139.64 | 2019-2024 | Grafix, Oasis, Stravix |
| Braintree Laboratories, INC. | $133.62 | 2019-2023 | Sutab |
| Merck Sharp & Dohme LLC | $103.37 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.95 | 2022-2023 | Gattex |
| Convatec INC. | $61.13 | 2020-2021 | |
| Intuitive Surgical, INC. | $36.37 | 2021 | |
| Palette Life Sciences, INC. | $30.23 | 2019 | |
| Avanos Medical | $30.01 | 2022 | |
| Terumo Medical Corporation | $28.89 | 2021 | |
| Heron Therapeutics, INC. | $26.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.35 | 2020 | |
| Kerecis Limited | $17.74 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.07 | 2025 | Columvi |
| Daiichi Sankyo INC. | $15.02 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $14.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asish Mukherjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.